Methods of a cluster-randomized, type II hybrid implementation effectiveness trial to prospectively assess extended-duration thromboprophylaxis for at-risk medical patients being discharged to prevent hospital-associated venous thromboembolism

Background: Venous thromboembolism (VTE) is the third leading cause of preventable hospital-associated (HA) death. Most HA-VTE, including fatal pulmonary emboli, occur among medically ill patients. The rate of symptomatic VTE more than doubles over the first 21 days after hospital discharge. Trials...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Scott C. Woller, Scott M. Stevens, Joseph R. Bledsoe, James Hellewell, Adam Kraft, Allison M. Butler, Masarret Fazili, James F. Lloyd, Paige S. Christensen, Ithan D. Peltan, Geoffrey D. Barnes, Benjamin D. Horne
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Elsevier 2024-08-01
Sarja:	Research and Practice in Thrombosis and Haemostasis
Aiheet:	extended-duration thromboprophylaxis medical patients prophylaxis risk score thrombosis venous thromboembolism
Linkit:	http://www.sciencedirect.com/science/article/pii/S2475037924002449
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!